Category: by journal

Springer purge of fake reviews takes down 10+ more neuroscience papers

Back in April, Springer retracted a record number 107 papers from Tumor Biology after uncovering evidence they were subject to fake peer reviews. But it appears that the Tumor Biology sweep was only part of the story.

During the Tumor Biology investigation, Springer found evidence that the “peer review process was compromised” in a dozen papers on brain cancer published in another journal. The 12 Molecular Neurobiology retractions have trickled in over the past year or so, published before and after the Tumor Biology sweep.

A spokesperson at Springer confirmed that the 12 retracted papers in Molecular Neurobiology were related to the Tumor Biology retractions for fake peer review: Continue reading Springer purge of fake reviews takes down 10+ more neuroscience papers

Quick: What does fish food have to do with X-rays? In this case, an Elsevier production error

An MRI of a fish, not involved in this study. (via Wikimedia)

In 2012, a study claiming to show — after some intentional statistical tricks — that a dead salmon had brain activity in an fMRI won a prestigious (and hilarious) Ig Nobel Prize.

So five years later, when Bálint Botz tweeted wryly about a study of fish and plants in a radiology journal, we thought, “Aha, someone is trying to create another red herring!”

But alas, it turns out the reason a journal normally concerned with X-rays would suddenly be interested in aquaponics was far more prosaic: Continue reading Quick: What does fish food have to do with X-rays? In this case, an Elsevier production error

When a tractor stabs a man in the eye, who gets to write up the case report?

A journal has retracted a paper after the university notified the editors that the authors presented the gruesome details of a patient who they didn’t directly treat.

But the paper’s corresponding author disputes that claim, arguing that the first author — a radiologist, who has since passed away, provided a crucial diagnosis in this case. We’ve tried to track down the doctors who lodged a complaint about the paper, alleging they were “actually involved in the original patient treatment,” but have so far been unsuccessful.

The paper describes an unfortunate accident during which a man fell from his tractor and stabbed himself in the eye on part of the machine. Initially, doctors could not locate the eye and “believed it to have been completely destroyed,” and discharged the patient after seven days. One week later he was back, complaining of headaches — and doctors found the eye embedded deep inside the skull, intact.

According to the retraction notice, issued by the Journal of Neuro-Ophthalmology, an investigation by a university in Iran determined the doctors who initially described the case didn’t have the right to do so: Continue reading When a tractor stabs a man in the eye, who gets to write up the case report?

Author of retracted gene editing paper alleges “bullying” by former PI

In the fall of 2015, out-of-work stem cell biologist Mavi Camarasa decided she had waited long enough. It had been three years since she and a colleague were, best they could tell, the first to successfully correct the most common cystic fibrosis mutation in stem cells derived from a patient.

But her former lab director, Daniel Bachiller, had blocked her from writing even a short report, she told Retraction Watch:

He said we are not submitting at this time, wait until [the project is] complete. “Wait, wait,” is the only answer I’d had from him ever.

Though she’d left the Spanish regenerative medicine lab in 2013 to take care of an ailing parent and had mostly been scooped by another group in April of that year, Camarasa thought she still might be able to get something out of the project. She hatched a plan to make him an offer he couldn’t refuse — an already accepted manuscript where all he would have to do is attach his name at the last minute.

But this story didn’t turn out exactly how she’d hoped — and illustrates how the pressure to publish can affect researchers at different levels in the lab.

Continue reading Author of retracted gene editing paper alleges “bullying” by former PI

OSU researcher under investigation corrects paper cited 500 times

An EMBO journal has issued a correction for a well-cited 2012 review co-authored by a cancer researcher under investigation.

Carlo Croce, the last author on the review, has been beleaguered by misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times), and his university has recently re-opened an investigation into his work.

By our count, Croce — based at The Ohio State University — has logged six retractions, along with multiple expressions of concerns and corrections. The latest correction, in EMBO Molecular Medicine, notes the review lifted passages from multiple publications — and was in turn reused in later papers, as well.

Here’s the notice:

Continue reading OSU researcher under investigation corrects paper cited 500 times

Journal won’t look at allegations about papers more than six years old, nor comment on those from “public websites”

After a paper is published, how long should a journal consider allegations of misconduct? For one journal, that answer is: Six years.

We see plenty of journals that retract papers at least 10 years old over concerns regarding misconduct, but in a recent editorial, Molecular and Cellular Biology announced it would pursue allegations made within six years after a paper is published. This rule mirrors federal regulations (which apply to the U.S. Office of Research Integrity), which also decline to investigate allegations if at least six years have passed since the incident supposedly occurred — but with some exceptions, such as if the misconduct could have an impact on public health.

Incidentally, the same issue of the journal includes a retraction notice for a paper published seven years ago, citing image duplications. A spokesperson for the American Society for Microbiology (which publishes the journal) told us the journal investigated the paper in 2016, within the cutoff period.

Here’s the key text from the editorial:

Continue reading Journal won’t look at allegations about papers more than six years old, nor comment on those from “public websites”

“Data had been manipulated:” Science Translational Medicine retracts paper

Science Translational Medicine has retracted a paper by researchers based in Switzerland, after an investigation concluded two figures had been manipulated.

The investigation occurred at the University of Basel. It’s not clear what prompted it, but the paper has been discussed at length on PubPeer. After the investigation concluded two figure panels included manipulated data, the last author asked to retract the paper.

Here’s the notice:

Continue reading “Data had been manipulated:” Science Translational Medicine retracts paper

“Authors’ negligence” causes “a plethora of data errors”

Sometimes, even a short notice catches our attention.

Such was the case with a recent retraction issued by Oncotarget for a 2016 paper related to the genetics that drive cancer.

Here’s the notice:

Continue reading “Authors’ negligence” causes “a plethora of data errors”

Rutgers prof announces retraction on his blog

A Rutgers computer scientist is retracting conference proceedings via an unusual channel: his personal blog.

On April 7, Anand Sarwate wrote that he was retracting a mathematical proof from the proceedings from the 2016 IEEE International Conference on Acoustics, Speech, and Signal Processing (ICASSP), after discovering errors that invalidated the result.

He explains in the blog post why the mistake occurred:

Continue reading Rutgers prof announces retraction on his blog

A retraction gets retracted — but the first author’s contract is still terminated

After issuing a retraction notice May 30 for a biomedical engineering paper, the journal has since pulled the notice, citing “a potential problem.”

After doing some digging, we’ve learned more about the “potential problem.”

Apparently, the retraction was requested by Nanyang Technological University (NTU) in Singapore. NTU has been investigating the first author for months, after it received an allegation about an unrelated manuscript. As a result, NTU terminated first author Hamidreza Namazi‘s contract as a research fellow earlier this year.

As part of the investigation, NTU began to look at Namazi’s other papers, and discovered several with potential problems — including this one, which NTU believes did not receive proper ethical approvals. So it contacted the journal to raise its concerns.

Namazi, however, told us that he and his colleague obtained approval from another organization, but didn’t make that clear in the paper — so the journal has retracted its retraction notice while it investigates Namazi’s claim.

In place of the original retraction notice, a notice now reads:

Continue reading A retraction gets retracted — but the first author’s contract is still terminated